HIV Infections: all 4,340 studies
Page 35 of 44. Open to participants first (240), then studies with results posted, then the rest; newest registration first within each.
- Effects of Maternal Anti-HIV Treatment on Infants Born to HIV-Infected WomenCompletedNCT00100867
- Anti-HIV Treatment Interruptions in HIV Infected Adults in South AfricaCompletedNCT00100646Not applicable
- Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected People in Wenxi County, Shanxi Province, ChinaCompletedNCT00100594Not applicable
- Safety, Effectiveness, and Tolerability of Ezetimibe Combined With Statins for the Treatment of High Cholesterol in HIV Infected AdultsCompletedNCT00099684Not applicable
- Safety of Interleukin-7 in HIV Infected People Currently Taking Anti-HIV DrugsCompletedNCT00099671Phase 1
- Anti-HIV Activity and Safety of 3 Different Doses of Mifepristone in HIV Infected PeopleCompletedNCT00099645Phase 1/2
- Safety of and Immune Response to an HIV-1 Vaccine (ALVAC-HIV vCP1521) in Infants Born to HIV Infected MothersCompletedNCT00098163Phase 1
- Safety of and Immune Response to an HIV-1 Subtype C Vaccine (AVX101) in HIV Uninfected AdultsCompletedNCT00097838Phase 1
- Retrovirus Epidemiology Donor Study-II (REDS-II)CompletedNCT00097006
- A Study of Dementia and Neurological Problems in HIV Infected Patients Who Are Participating in ACTG A5175CompletedNCT00096824
- Collection of Blood Samples From HIV Infected PeopleCompletedNCT00096772
- Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected SubjectsCompletedNCT00096746
- Effect of an Intrauterine Contraceptive Device (IUD) in HIV Infected WomenCompletedNCT00096694Not applicable
- Fosamprenavir Versus Other Protease InhibitorsCompletedNCT00094523Phase 3
- A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study)CompletedNCT00094367Phase 3
- HIV Assessment in Fuyang, Anhui Province, ChinaCompletedNCT00094354
- Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease ActivityActive, not recruitingNCT00092222Phase 2
- Efficacy of Elevated CD4 Counts on CMV RetinitisCompletedNCT00091884
- Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected SubjectsCompletedNCT00091741Phase 1
- Safety of and Immune Response to an HIV-1 Vaccine Boost (VRC-HIVADV014-00-VP) in HIV Uninfected Adults Who Participated in HVTN 052CompletedNCT00091416Phase 1
- Monotherapy Versus Placebo Over 7 Days-Non-Nucleoside Reverse Transcriptase Inhibitor-Experienced HIV1 Infected AdultsCompletedNCT00090077Phase 1
- TNX-355 With Optimized Background Therapy (OBT) in Treatment-Experienced Subjects With HIV-1Status unknownNCT00089700Phase 2
- An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic PainTerminatedNCT00089557Phase 2
- Candidate HIV VaccineCompletedNCT00089531Phase 1
- A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected PatientsCompletedNCT00089492Phase 2
- Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected PatientsCompletedNCT00089466Phase 1/2
- Effect of Tenofovir DF on Bone Metabolism in ChildrenCompletedNCT00088309Phase 2
- Blood Levels of Abacavir in HIV Infected AdolescentsCompletedNCT00087945Not applicable
- Study of Enfuvirtide in HIV-Positive SubjectsCompletedNCT00086710Phase 1
- Long-term Follow-up of HIV Infected Patients Identified During Early InfectionCompletedNCT00086372
- Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIVCompletedNCT00086359Phase 3
- KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 WeeksCompletedNCT00085943Phase 3
- Study of NGX-4010 for Treatment of Painful HIV-Associated NeuropathyTerminatedNCT00085761Phase 3
- Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive PatientsCompletedNCT00084253Phase 4
- Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIVCompletedNCT00084058Phase 1/2
- Voluntary HIV Counseling, Testing, and Medication for Pregnant Women to Prevent Mother-to-Child HIV TransmissionCompletedNCT00084045Not applicable
- Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIVWithdrawnNCT00084032Not applicable
- Atazanavir/Ritonavir Maintenance TherapyCompletedNCT00084019Not applicable
- Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected AdultsCompletedNCT00083603Phase 1
- Safety and Immunogenicity of an HIV Vaccine in Normal Adult VolunteersCompletedNCT00083330Phase 1
- Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected PatientsCompletedNCT00082498Phase 2
- A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIVCompletedNCT00082394Phase 4
- Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic PainCompletedNCT00082316Phase 2
- TMC125-C223: TMC125 in HIV-1 Infected SubjectsCompletedNCT00081978Phase 2
- Safety and Acceptability of PRO 2000 Vaginal Gel in HIV Uninfected Women in IndiaCompletedNCT00081640Phase 1
- An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects.CompletedNCT00081588Phase 2
- Strategies for Delivering Anti-HIV Therapy in South AfricaCompletedNCT00080522Not applicable
- Daclizumab to Treat HIV-Infected PatientsCompletedNCT00080431Phase 1
- Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected PatientsCompletedNCT00080106Phase 2
- Increasing Condom Use in People at Risk for HIV InfectionStatus unknownNCT00080093Not applicable
- Directly Observed Therapy in HIV Infected Adolescent Focus GroupsCompletedNCT00079729
- Distant Healing for HIV/AIDSCompletedNCT00079534Not applicable
- Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected PeopleCompletedNCT00078442Phase 2
- Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in CambodiaWithdrawnNCT00078182Phase 2/3
- Safety of the EnvPro HIV Vaccine in Healthy VolunteersCompletedNCT00076947Phase 1
- Safety and Effectiveness of Administering an HIV Vaccine in the Groin Versus the ArmCompletedNCT00076817Phase 1
- Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their InfantsCompletedNCT00076791Phase 1
- GW873140 to Treat HIV-1 Infected AdultsCompletedNCT00076284Phase 2
- A Study of Acyclovir to Help Prevent HIV Infection in People With Genital HerpesCompletedNCT00076232Phase 3
- A Study of LIPO-5 and ALVAC-HIV (vCP1452) as Possible HIV VaccinesCompletedNCT00076063Phase 1/2
- Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEPCompletedNCT00076037Phase 1
- Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected AdolescentsCompletedNCT00075907Phase 3
- A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected SubjectsCompletedNCT00075231Phase 2
- Quality of Life in Children With HIV InfectionCompletedNCT00075153
- A Study of Male Rectal Samples in Preparation for Future Rectal Microbicide TrialsCompletedNCT00075062
- BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in WomenCompletedNCT00074425Phase 2
- Nevirapine (NVP) Use to Prevent Mother-to-Child Transmission of HIVCompletedNCT00074399Phase 3
- Immune Function of Infants With HIVCompletedNCT00073229
- Safety of and Immune Response to a Combination HIV Vaccine Regimen in HIV Uninfected AdultsCompletedNCT00073216Phase 1
- Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected AdultsCompletedNCT00071851Phase 1/2
- An Electronic Pillbox for People With HIVStatus unknownNCT00071500Phase 1
- Growth Hormone to Increase Immune Function in People With HIVCompletedNCT00071240Phase 2
- TMC114-C202: A Study of Safety, Efficacy, and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected PatientsCompletedNCT00071097Phase 2
- Massage to Increase Well-Being and Immune Function in Dominican Children Infected With HIVCompletedNCT00070980Not applicable
- Immune Response to Influenza Vaccine in HIV-Infected IndividualsCompletedNCT00069914
- Effect of an Anti-Inflammatory Drug on Gut Mucosa in HIV Infected PatientsCompletedNCT00069498Phase 1
- Resistance to HIV InfectionStatus unknownNCT00069485
- Safety of and Immune Response to an HIV Vaccine (VRC-HIVDNA009-00-VP) Administered With Interleukin-2/Immunoglobulin (IL-2/Ig) DNA Adjuvant in Uninfected AdultsCompletedNCT00069030Phase 1
- HIV Educational Programs for Villagers of Funan County or Yingzhou District, Anhui Province, ChinaWithdrawnNCT00068991Phase 1
- Analysis of Immune Responses to HIV VaccinesCompletedNCT00068978
- 4-Day-A-Week Treatment Plan for HIV Infected AdolescentsCompletedNCT00068809Phase 4
- Evaluating Immune Function Tests in People With HIVCompletedNCT00067795
- A Phase IIIB Study Evaluating the Effect on Serum Lipids Following a Switch to Atazanavir in HIV Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral TherapyCompletedNCT00067782Phase 3
- Emotional Disclosure in HIVCompletedNCT00067704Not applicable
- Treatment Plan to Decrease Drug Exposure in HIV Infected AdolescentsWithdrawnNCT00067574Not applicable
- Preventing Unplanned Pregnancies in HIV Infected Zambian CouplesStatus unknownNCT00067522Not applicable
- Antiviral Therapy and HIV in the Female Genital TractCompletedNCT00067106
- HIV Symptom Management Program for African American MothersCompletedNCT00065819Phase 3
- Dehydroepiandrosterone Effects on HIV-1 ReplicationCompletedNCT00065104Phase 2
- Relaxation Response With Acupuncture for HIV PatientsCompletedNCT00064740Phase 2
- Study of NGX-4010 for the Treatment of Painful HIV-Associated NeuropathyCompletedNCT00064623Phase 3
- Safety of AMD070 When Administered Alone or Boosted With Low-Dose Ritonavir in HIV Uninfected MenCompletedNCT00063804Phase 1
- Safety of an HIV Vaccine (AVX101) in HIV Uninfected Volunteers in the United States and South AfricaCompletedNCT00063778Phase 1
- Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV InfectionApproved for marketingNCT00062660
- Education Program to Promote Female Condom UseStatus unknownNCT00062634Not applicable
- Safety of an Oral HIV Vaccine in HIV Uninfected VolunteersStatus unknownNCT00062530Phase 1
- Daily Nevirapine to Prevent Mother to Infant Transmission of HIVCompletedNCT00061321Phase 3
- The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected PatientsCompletedNCT00061256Phase 2
- Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected AdultsStatus unknownNCT00061243Phase 1
- Pilot Study of High-Concentration Capsaicin Patches in the Treatment of Painful HIV-Associated NeuropathyStatus unknownNCT00061152Phase 2